Adial Pharmaceuticals (ADIL)

• Market cap: $2.67M
• 1 day: 10%
• 5 days: -1.06%
• 1 month: -26.95%
• 3 months: -68.89%
• 6 months: -78.63%
• Year to date: -68.73%
• 1 year: -89.67%
• 5 years: -99.88%
• 10 years: -99.93%
• Sector: Healthcare
• Industry: Biotechnology

About: Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Employees: 6